Advertisement
Advertisement
IVA
Inventiva S.A. - ADR
5.90
USDSponsored
+0.10
+1.74%
Feb 06, 16:00 UTC -5
Closed
After-Market
5.88
-0.03
-0.44%
IVA Earnings Reports
Positive Surprise Ratio
No Data Available for IVA
0%
Next Report
Date of Next Report
Feb 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.24
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/--
Inventiva S.A. - ADR earnings per share and revenue
On Nov 21, 2025, IVA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.25 USD, resulting in a --% surprise. Revenue reached 46.00 thousand, compared to an expected 8.72 million, with a -99.47% difference.
Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and decrease of -100.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
FAQ
What were Inventiva S.A. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Inventiva S.A. - ADR reported EPS of --, missing estimates by --, and revenue of $46.00K, -99.47% below expectations.
How did the market react to Inventiva S.A. - ADR's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Inventiva S.A. - ADR expected to report next?
The next earning report is scheduled for Feb 16, 2026.
What are the forecasts for Inventiva S.A. - ADR's next earnings report?
Based on 2
analysts, Inventiva S.A. - ADR is expected to report EPS of -$0.24 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement